Outcomes after meniscal repair using the meniscus arrow
in knees undergoing anterior cruciate ligament reconstruction.
Both complaints charge infringement of a patent covering the company's Meniscus Arrow
. The first suit names Linvatec Corporation as a Defendant and has been brought in the District Court for the Southern District of New York.
Deteriorating outcomes after meniscal repair using the Meniscus Arrow
in knees undergoing concurrent anterior cruciate ligament reconstruction: increased failure rate with long-term follow-up.
The investigators found that surgical time was cut in half using the meniscus arrow
, and that "there was no statistical differences in healing (total and partial) between arrows and sutures in the subgroups with isolated lesions, lesions in ACL-reconstructed knees, and lesions in ACL-insufficient knees." These results have been verified in recent clinical studies.